Correlation Between Merrimack Pharmaceuticals and Achilles Therapeutics
Can any of the company-specific risk be diversified away by investing in both Merrimack Pharmaceuticals and Achilles Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merrimack Pharmaceuticals and Achilles Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merrimack Pharmaceuticals and Achilles Therapeutics PLC, you can compare the effects of market volatilities on Merrimack Pharmaceuticals and Achilles Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merrimack Pharmaceuticals with a short position of Achilles Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merrimack Pharmaceuticals and Achilles Therapeutics.
Diversification Opportunities for Merrimack Pharmaceuticals and Achilles Therapeutics
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Merrimack and Achilles is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Merrimack Pharmaceuticals and Achilles Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Achilles Therapeutics PLC and Merrimack Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merrimack Pharmaceuticals are associated (or correlated) with Achilles Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Achilles Therapeutics PLC has no effect on the direction of Merrimack Pharmaceuticals i.e., Merrimack Pharmaceuticals and Achilles Therapeutics go up and down completely randomly.
Pair Corralation between Merrimack Pharmaceuticals and Achilles Therapeutics
Given the investment horizon of 90 days Merrimack Pharmaceuticals is expected to generate 9.03 times less return on investment than Achilles Therapeutics. But when comparing it to its historical volatility, Merrimack Pharmaceuticals is 3.26 times less risky than Achilles Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Achilles Therapeutics PLC is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 120.00 in Achilles Therapeutics PLC on October 25, 2024 and sell it today you would lose (5.66) from holding Achilles Therapeutics PLC or give up 4.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 23.89% |
| Values | Daily Returns |
Merrimack Pharmaceuticals vs. Achilles Therapeutics PLC
Performance |
| Timeline |
| Merrimack Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Achilles Therapeutics PLC |
Merrimack Pharmaceuticals and Achilles Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Merrimack Pharmaceuticals and Achilles Therapeutics
The main advantage of trading using opposite Merrimack Pharmaceuticals and Achilles Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merrimack Pharmaceuticals position performs unexpectedly, Achilles Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achilles Therapeutics will offset losses from the drop in Achilles Therapeutics' long position.| Merrimack Pharmaceuticals vs. Amicus Therapeutics | Merrimack Pharmaceuticals vs. Celldex Therapeutics | Merrimack Pharmaceuticals vs. Puma Biotechnology | Merrimack Pharmaceuticals vs. Agios Pharm |
| Achilles Therapeutics vs. Assembly Biosciences | Achilles Therapeutics vs. Spero Therapeutics | Achilles Therapeutics vs. Instil Bio | Achilles Therapeutics vs. Nuvation Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |